No significant effect on perilipin-2 LFQ intensity in hPod was detected after exposure to (disease) controls, FCS, healthy plasma, or plasma from a patient with IgA nephropathy (IgA), or two patients with non-recurrent FSGS (nonrec1, nonrec2) (Figure 2A). The gene discussed is CD79A; the disease is IgA glomerulonephritis.